Contact, publication, and social network information about Harvard faculty and fellows. Harvard Catalyst Profiles
Keywords
Last Name
Institution

Frederic Ira Preffer, Ph.D.

TitleAssociate Professor of Pathology
InstitutionMassachusetts General Hospital
DepartmentPathology
AddressMassachusetts General Hospital
C P Z N, Rm 4226
185 Cambridge St
Boston MA 02114
Phone617/726-7481
Fax617/724-3164

 Mentoring 
 current student opportunities
Available: 11/01/13, Expires: 08/29/14

This study is an attempt to better characterize the bone marrow and/or blood of patients with the indicated malignancy by flow cytometry, to detect immunophenotypically low levels of disease. Such detection is critical to disease management.


 Research 
 research resources
This researcher has shared information about their research resources
in the eagle-i Network. To update or add resource records, contact
eagle-i@hms.harvard.edu.
Flow Cytometry Core Facility (MGH) - Core services (1) and Instruments (4)

 Bibliographic 
 selected publications
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
List All   |   Timeline
  1. Marti GE, Mandy F, Denny T, Preffer FI. Concerning the article by de Carvalho Bittencourt et al.: Value of HIV patients with regular follow-up as in-house internal controls of flow cytometry measurement of lymphocyte subsets. Cytometry B Clin Cytom. 2013 Sep; 84(5):327-8.
    View in: PubMed
  2. Platt MY, Delelys ME, Preffer FI, Sohani AR. Response to wu et Al. Cytometry B Clin Cytom. 2013 Nov; 84(6):399.
    View in: PubMed
  3. Platt MY, Delelys ME, Preffer FI, Sohani AR. Flow cytometry is of limited utility in the early identification of "Double-hit" B-cell lymphomas. Cytometry B Clin Cytom. 2013 May; 84(3):143-8.
    View in: PubMed
  4. Krause DS, Scadden DT, Preffer FI. The hematopoietic stem cell niche-home for friend and foe? Cytometry B Clin Cytom. 2013 Jan; 84(1):7-20.
    View in: PubMed
  5. Nishida A, Nagahama K, Imaeda H, Ogawa A, Lau CW, Kobayashi T, Hisamatsu T, Preffer FI, Mizoguchi E, Ikeuchi H, Hibi T, Fukuda M, Andoh A, Blumberg RS, Mizoguchi A. Inducible colitis-associated glycome capable of stimulating the proliferation of memory CD4+ T cells. J Exp Med. 2012 Dec 17; 209(13):2383-94.
    View in: PubMed
  6. Delelys ME, Ochoa G, Cserti-Gazdewich CM, Vietz C, Preffer FI, Dzik W. Relationship between ABO genotype and A antigen expression on platelets. Transfusion. 2013 Aug; 53(8):1763-71.
    View in: PubMed
  7. Preffer FI. Issue highlights november 2012. Cytometry B Clin Cytom. 2012 Nov; 82(6):343-4.
    View in: PubMed
  8. Fathi AT, Preffer FI, Sadrzadeh H, Ballen KK, Amrein PC, Attar EC, McAfee SL, Dillon L, Chen YB, Hasserjian RP. CD30 expression in acute myeloid leukemia is associated with FLT3-internal tandem duplication mutation and leukocytosis. Leuk Lymphoma. 2013 Apr; 54(4):860-3.
    View in: PubMed
  9. Hasserjian RP, Preffer FI. Flow cytometry to distinguish myelodysplastic syndromes from non-neoplastic causes of cytopenia: ready for prime time? Leuk Res. 2012 Sep; 36(9):1089-90.
    View in: PubMed
  10. Preffer FI. Mea maxima culpa!: Letter to the new editor…From your new editor. Cytometry B Clin Cytom. 2012 Mar; 82(2).
    View in: PubMed
  11. Meirelles K, Benedict LA, Dombkowski D, Pepin D, Preffer FI, Teixeira J, Tanwar PS, Young RH, MacLaughlin DT, Donahoe PK, Wei X. Human ovarian cancer stem/progenitor cells are stimulated by doxorubicin but inhibited by Mullerian inhibiting substance. Proc Natl Acad Sci U S A. 2012 Feb 14; 109(7):2358-63.
    View in: PubMed
  12. Preffer FI, Gratama JW. Clinical Cytometry on both sides of the Atlantic, 2011. Cytometry B Clin Cytom. 2011 Nov; 80(6):373-4.
    View in: PubMed
  13. Preffer FI. Issue highlights-clinical cytometry (cytometry part B) November 2011. Cytometry B Clin Cytom. 2011 Nov; 80(6):343.
    View in: PubMed
  14. Hansen P, Barry D, Restell A, Sylvia D, Magnin O, Dombkowski D, Preffer F. Physics of a rapid CD4 lymphocyte count with colloidal gold. Cytometry A. 2012 Mar; 81(3):222-31.
    View in: PubMed
  15. Farris AB, Taheri D, Kawai T, Fazlollahi L, Wong W, Tolkoff-Rubin N, Spitzer TR, Iafrate AJ, Preffer FI, Locascio SA, Sprangers B, Saidman S, Smith RN, Cosimi AB, Sykes M, Sachs DH, Colvin RB. Acute renal endothelial injury during marrow recovery in a cohort of combined kidney and bone marrow allografts. Am J Transplant. 2011 Jul; 11(7):1464-77.
    View in: PubMed
  16. Andreola G, Chittenden M, Shaffer J, Cosimi AB, Kawai T, Cotter P, Locascio SA, Morokata T, Dey BR, Tolkoff-Rubin NT, Preffer F, Bonnefoix T, Kattleman K, Spitzer TR, Sachs DH, Sykes M. Mechanisms of donor-specific tolerance in recipients of haploidentical combined bone marrow/kidney transplantation. Am J Transplant. 2011 Jun; 11(6):1236-47.
    View in: PubMed
  17. Novershtern N, Subramanian A, Lawton LN, Mak RH, Haining WN, McConkey ME, Habib N, Yosef N, Chang CY, Shay T, Frampton GM, Drake AC, Leskov I, Nilsson B, Preffer F, Dombkowski D, Evans JW, Liefeld T, Smutko JS, Chen J, Friedman N, Young RA, Golub TR, Regev A, Ebert BL. Densely interconnected transcriptional circuits control cell states in human hematopoiesis. Cell. 2011 Jan 21; 144(2):296-309.
    View in: PubMed
  18. LoCascio SA, Morokata T, Chittenden M, Preffer FI, Dombkowski DM, Andreola G, Crisalli K, Kawai T, Saidman SL, Spitzer TR, Tolkoff-Rubin N, Cosimi AB, Sachs DH, Sykes M. Mixed chimerism, lymphocyte recovery, and evidence for early donor-specific unresponsiveness in patients receiving combined kidney and bone marrow transplantation to induce tolerance. Transplantation. 2010 Dec 27; 90(12):1607-15.
    View in: PubMed
  19. Wei X, Dombkowski D, Meirelles K, Pieretti-Vanmarcke R, Szotek PP, Chang HL, Preffer FI, Mueller PR, Teixeira J, MacLaughlin DT, Donahoe PK. Mullerian inhibiting substance preferentially inhibits stem/progenitors in human ovarian cancer cell lines compared with chemotherapeutics. Proc Natl Acad Sci U S A. 2010 Nov 2; 107(44):18874-9.
    View in: PubMed
  20. Stone. Protein kinase CK1áLS promotes vascular cell proliferation and intimal hyperplasia. 2010; In Press.
  21. Panchenko MP, Siddiquee Z, Dombkowski DM, Alekseyev YO, Lenburg ME, Walker JD, Macgillivray TE, Preffer FI, Stone JR. Protein kinase CK1alphaLS promotes vascular cell proliferation and intimal hyperplasia. Am J Pathol. 2010 Sep; 177(3):1562-72.
    View in: PubMed
  22. Cannizzo E, Bellio E, Sohani AR, Hasserjian RP, Ferry JA, Dorn ME, Sadowski C, Bucci JJ, Carulli G, Preffer F. Multiparameter immunophenotyping by flow cytometry in multiple myeloma: The diagnostic utility of defining ranges of normal antigenic expression in comparison to histology. Cytometry B Clin Cytom. 2010 Jul; 78(4):231-8.
    View in: PubMed
  23. Cannizzo E, Bellio E, Sohani AR, Hasserjian RP, Ferry JA, Dorn ME, Sadowski C, Bucci JJ, Carulli G, Preffer FI. Multiparameter immunophenotyping by flow cytometry in multiple myeloma: the diagnostic utility of defining ranges of normal antigenic expression in comparison to histology. Cytometry. 2010; 78B(4):231-238.
  24. Dzik WH, Cserti-Gazdewich CM, Ssewanyana I, Delelys M, Preffer FI. When monocytes and platelets compete: The effect of platelet count on the flow cytometric measurement of monocyte CD36. Cytometry B Clin Cytom. 2010 Mar; 78(2):81-7.
    View in: PubMed
  25. Dzik WH, Cserti-Gazdewich C, Ssewanyana I, Delelys M, Preffer FI . When monocytes and platelets compete: the effect of platelet count on the flow cytometric measurement of monocyte CD36. Cytometry. 2010; 78B(4):81-87.
  26. Hulspas R, Dombkowski D, Preffer F, Douglas D, Kildew-Shah B, Gilbert J. Flow cytometry and the stability of phycoerythrin-tandem dye conjugates. Cytometry A. 2009 Nov; 75(11):966-72.
    View in: PubMed
  27. Chang HL, Senaratne TN, Zhang L, Szotek PP, Stewart E, Dombkowski D, Preffer F, Donahoe PK, Teixeira J. Uterine leiomyomas exhibit fewer stem/progenitor cell characteristics when compared with corresponding normal myometrium. Reproductive Science. 2009; 17(2):158-167.
  28. Chang HL, Senaratne TN, Zhang L, Szotek PP, Stewart E, Dombkowski D, Preffer F, Donahoe PK, Teixeira J. Uterine leiomyomas exhibit fewer stem/progenitor cell characteristics when compared with corresponding normal myometrium. Reprod Sci. 2010 Feb; 17(2):158-67.
    View in: PubMed
  29. Preffer FI and Dombkowski DD. Advances in Complex Multiparameter Flow Cytometry Technology: Applications in Stem Cell Research. Cytometry. 2009; 76B(5):295-314.
  30. Preffer F, Dombkowski D. Advances in complex multiparameter flow cytometry technology: Applications in stem cell research. Cytometry B Clin Cytom. 2009 Sep; 76(5):295-314.
    View in: PubMed
  31. Cannizzo E, Sohani AR, Ferry JA, Hochberg EP, Kluk MJ, Dorn ME, Sadowski C, Bucci JJ, Ackerman AM, Longtine JA, Carulli G, Preffer FI. Carcinoma and multiple lymphomas in one patient: establishing the diagnoses and analyzing risk factors. J Hematop. 2009; 2(3):163-70.
    View in: PubMed
  32. Cserti-Gazdewich CM, Dzik WH, Dorn ME, Quagliaroli RO, Xu S, Ssewanyana I, Nayyar R, Preffer FI. Quantitation of CD36 (platelet glycoprotein IV) expression on platelets and monocytes by flow cytometry: application to the study of Plasmodium falciparum malaria. Cytometry B Clin Cytom. 2009 Mar; 76(2):127-34.
    View in: PubMed
  33. Rahemtullah A, Longtine JA, Harris NL, Dorn M, Zembowicz A, Quintanilla-Fend L, Preffer FI, Ferry JA. CD20+ T-cell lymphoma: clinicopathologic analysis of 9 cases and a review of the literature. Am J Surg Pathol. 2008 Nov; 32(11):1593-607.
    View in: PubMed
  34. Cserti-Gazdewich C, Dzik W, Dorn M, Quagliaroli R, Xu S, Ssewanyana I, Nayyar R, and Preffer F. Quantitation of CD36 (Platelet Glycoprotein IV) Expression on Platelets and Monocytes by Flow Cytometry: Application to the study of Plasmodium falciparum Malaria. Cytometry Part B (Clinical Cytometry)In Press. 2008.
  35. Rahemtullah A, Harris NL, Dorn ME, Preffer FI, Hasserjian RP. Beyond the lymphocyte predominant cell: CD4+CD8+ T-cells in nodular lymphocyte predominant Hodgkin lymphoma. Leuk Lymphoma. 2008 Oct; 49(10):1870-8.
    View in: PubMed
  36. Szotek P, Chang H, Brennand K, Fujino A, Pieretti-Vanmarcke R, Lo Celso C, Dombkowski D, Preffer F, Cohen K, Teixeira J, and Donanhoe P. Normal Ovarian Surface Epithelial Label Retaining Cells Exhibit Stem/Progenitor Cell Characteristics. Proc Natl Acad Sci USA. 2008; 105(34):12469-12473.
  37. Szotek PP, Chang HL, Brennand K, Fujino A, Pieretti-Vanmarcke R, Lo Celso C, Dombkowski D, Preffer F, Cohen KS, Teixeira J, Donahoe PK. Normal ovarian surface epithelial label-retaining cells exhibit stem/progenitor cell characteristics. Proc Natl Acad Sci U S A. 2008 Aug 26; 105(34):12469-73.
    View in: PubMed
  38. Rahemtullah A, Harris N, Dorn M, Preffer F and Hasserjian R . Beyond the L&H Cell: CD4+CD8+ T Cells in Nodular Lymphocyte Predominant Hodgkin’s Lymphoma . Leukemia and Lymphoma. 2008; 49(10):1870-1878.
  39. Ting DT, Spitzer TR, Chaudhary A, Muzikansky A, Colby C, Power K, McAfee S, Ballen K, Attar E, Saidman SL, Preffer F, Sykes M, Dey BR. Clinical outcomes of late rather than early full-donor chimerism in patients with advanced lymphomas receiving nonmyeloablative allogeneic hematopoietic SCT. Bone Marrow Transplant. 2008 Sep; 42(5):329-35.
    View in: PubMed
  40. Lu J, Guo S, Ebert BL, Zhang H, Peng X, Bosco J, Pretz J, Schlanger R, Wang JY, Mak RH, Dombkowski DM, Preffer FI, Scadden DT, Golub TR. MicroRNA-mediated control of cell fate in megakaryocyte-erythrocyte progenitors. Dev Cell. 2008 Jun; 14(6):843-53.
    View in: PubMed
  41. Kawai T, Cosimi AB, Spitzer TR, Tolkoff-Rubin N, Suthanthiran M, Saidman SL, Shaffer J, Preffer FI, Ding R, Sharma V, Fishman JA, Dey B, Ko DS, Hertl M, Goes NB, Wong W, Williams WW, Colvin RB, Sykes M, Sachs DH. HLA-mismatched renal transplantation without maintenance immunosuppression. N Engl J Med. 2008 Jan 24; 358(4):353-61.
    View in: PubMed
  42. Giovanna Andreola, Meredith Chittenden, Juanita Shaffer, A. Benedict Cosimi, Tatsuo Kawai, Pete Cotter, Bimalangshu R. Dey, Nina Tolkoff-Rubin, Frederic Preffer, Susan Saidman, Kristin Kattleman, Thomas R. Spitzer, David H. Sachs, and Megan Sykes. A Role for Regulatory Cells in Tolerance Induction in Recipients of Haploidentical Combined Non-Myeloablative Bone Marrow and Kidney Transplantation . Blood. 2007; 3255.
  43. Christine M. Cserti, Songyi Xu, Robert Sutherland, Rakesh Nayar, Marciano Reis, Michelle E. Dorn, Robert O. Quagliaroli, John D. Sullivan, Frederic I. Preffer, and Walter H. Dzik. Quantitative Flow Cytometric Assessment of CD36 (Platelet Glycoprotein IV) Expression on Monocytes and Platelets: Assay Development, Role in Plasmodium falciparum Risk Assessment, and Relationship to Sickle Hemoglobin. Blood. 2007; 110:3857.
  44. Bimalangshu R. Dey, Andrew J. Yee, Steven McAfee, Christine Dube, Karen Ballen, Eyal Attar, Christine Colby, Susan Saidman, Karen Malikowski, Frederic Preffer, Megan Sykes, and Thomas R. Spitzer. Non-Myeloablative T-Cell Depleted (TCD) Haploidentical Hematopoietic Cell Transplantation (HCT) Followed by Donor Leukocyte Infusion(s) for Hematologic Malignancies: The MGH Experience. . Blood. 2007.
  45. 1) Patricia K. Donahoe 2) Paul P. Szotek 3) David T. MacLaughlin 4) Frederic Preffer 5) Rafael Pieretti-Vanmarcke 6) David Dombkowski . METHODS TO IDENTIFY AND ENRICH FOR POPULATIONS OF OVARIAN CANCER STEM CELLS AND SOMATIC OVARIAN STEM CELLS AND USES THEREOF. 2007.
  46. Shaffer J, Villard J, Means TK, Alexander S, Dombkowski D, Dey BR, McAfee S, Ballen KK, Saidman S, Preffer FI, Sachs DH, Spitzer TR, Sykes M. Regulatory T-cell recovery in recipients of haploidentical nonmyeloablative hematopoietic cell transplantation with a humanized anti-CD2 mAb, MEDI-507, with or without fludarabine. Exp Hematol. 2007 Jul; 35(7):1140-52.
    View in: PubMed
  47. Dey BR, Shaffer J, Yee AJ, McAfee S, Caron M, Power K, Ting DT, Colby C, Preffer F, Ballen K, Attar E, Saidman S, Tarbell N, Sachs D, Sykes M, Spitzer TR. Comparison of outcomes after transplantation of peripheral blood stem cells versus bone marrow following an identical nonmyeloablative conditioning regimen. Bone Marrow Transplant. 2007 Jul; 40(1):19-27.
    View in: PubMed
  48. Szotek PP, Chang HL, Zhang L, Preffer F, Dombkowski D, Donahoe PK, Teixeira J. Adult mouse myometrial label-retaining cells divide in response to gonadotropin stimulation. Stem Cells. 2007 May; 25(5):1317-25.
    View in: PubMed
  49. Ferry JA, Fung CY, Zukerberg L, Lucarelli MJ, Hasserjian RP, Preffer FI, Harris NL. Lymphoma of the ocular adnexa: A study of 353 cases. Am J Surg Pathol. 2007 Feb; 31(2):170-84.
    View in: PubMed
  50. Rahemtullah A, Reichard KK, Preffer FI, Harris NL, Hasserjian RP. A double-positive CD4+CD8+ T-cell population is commonly found in nodular lymphocyte predominant Hodgkin lymphoma. Am J of Clin Pathol. 2006; 126(5):805-814.
  51. Klein J. and Preffer F. New and Improved Diagnostics Save Timea and Improve Outcomes for Cancer Patients. 2006.
  52. Szotek PP, Pieretti-Vanmarcke R, Masiakos PT, Dinulescu DM, Connolly D, Foster R, Dombkowski D, Preffer F, Maclaughlin DT, Donahoe PK. Ovarian cancer side population defines cells with stem cell-like characteristics and Mullerian Inhibiting Substance responsiveness. Proc Natl Acad Sci U S A. 2006 Jul 25; 103(30):11154-9.
    View in: PubMed
  53. Fudaba Y, Spitzer TR, Shaffer J, Kawai T, Fehr T, Delmonico F, Preffer F, Tolkoff-Rubin N, Dey BR, Saidman SL, Kraus A, Bonnefoix T, McAfee S, Power K, Kattleman K, Colvin RB, Sachs DH, Cosimi AB, Sykes M. Myeloma responses and tolerance following combined kidney and nonmyeloablative marrow transplantation: in vivo and in vitro analyses. Am J Transplant. 2006 Sep; 6(9):2121-33.
    View in: PubMed
  54. Kelliher AS, Parent DW, Anderson DC, Dorn ME, Hahn JL, Eapen S, Preffer FI. Novel use of the BD FACS SPA to automate custom monoclonal antibody panel preparations for immunophenotyping. Cytometry B Clin Cytom. 2005 Jul; 66(1):40-5.
    View in: PubMed
  55. Dey BR, McAfee S, Colby C, Cieply K, Caron M, Saidman S, Preffer F, Shaffer J, Tarbell N, Sackstein R, Sachs D, Sykes M, Spitzer TR. Anti-tumour response despite loss of donor chimaerism in patients treated with non-myeloablative conditioning and allogeneic stem cell transplantation. Br J Haematol. 2005 Feb; 128(3):351-9.
    View in: PubMed
  56. Preffer F. Clinical monitoring of transplant immunomodulation: Immunosuppression and T-cell Pathology Resident Instructions in Clinical Flow Cytometry. 2005.
  57. Treon SP, Emmanouilides C, Kimby E, Kelliher A, Preffer F, Branagan AR, Anderson KC, Frankel SR. Extended rituximab therapy in Waldenström's macroglobulinemia. Ann Oncol. 2005 Jan; 16(1):132-8.
    View in: PubMed
  58. Olson DP, Dombkowski DM, Kelliher AS, Pontillo C, Anderson DC, Preffer FI. Differential expression of cell surface antigens on subsets of CD4+ and CD8+ T cells. Med Sci Monit. 2004 Sep; 10(9):BR339-45.
    View in: PubMed
  59. Kradin RL, Sakamoto H, Jain F, Zhao LH, Hymowitz G, Preffer F. IL-10 inhibits inflammation but does not affect fibrosis in the pulmonary response to bleomycin. Exp Mol Pathol. 2004 Jun; 76(3):205-11.
    View in: PubMed
  60. Dombkowski D, Kelliher A, Anderson D, Dorn M, Harris NL, Preffer FI. The Use of 11-color Flow Cytometry in the Diagnosis of Hematologic Malignancy. ISAC XXII, Montpellier, France. 2004.
  61. Kuhlencordt PJ, Rosel E, Gerszten RE, Morales-Ruiz M, Dombkowski D, Atkinson WJ, Han F, Preffer F, Rosenzweig A, Sessa WC, Gimbrone MA, Ertl G, Huang PL. Role of endothelial nitric oxide synthase in endothelial activation: insights from eNOS knockout endothelial cells. Am J Physiol Cell Physiol. 2004 May; 286(5):C1195-202.
    View in: PubMed
  62. Dombkowski D, Kelliher A, Anderson D, Dorn M, Harris NL, Preffer F. The Use of 11-color Flow Cytometry in the Diagnosis of Hematologic Malignancy. 2004.
  63. Ichiyasu H, McCormack JM, McCarthy KM, Dombkowski D, Preffer FI, Schneeberger EE. Matrix metalloproteinase-9-deficient dendritic cells have impaired migration through tracheal epithelial tight junctions. Am J Respir Cell Mol Biol. 2004 Jun; 30(6):761-70.
    View in: PubMed
  64. Gu G, Wells JM, Dombkowski D, Preffer F, Aronow B, Melton DA. Global expression analysis of gene regulatory pathways during endocrine pancreatic development. Development. 2004 Jan; 131(1):165-79.
    View in: PubMed
  65. Koenecke C, Shaffer J, Alexander SI, Preffer F, Dombkowski D, Saidman SL, Dey B, McAfee S, Spitzer TR, Sykes M. NK cell recovery, chimerism, function, and recognition in recipients of haploidentical hematopoietic cell transplantation following nonmyeloablative conditioning using a humanized anti-CD2 mAb, Medi-507. Exp Hematol. 2003 Oct; 31(10):911-23.
    View in: PubMed
  66. Kraus AB, Shaffer J, Toh HC, Preffer F, Dombkowski D, Saidman S, Colby C, George R, McAfee S, Sackstein R, Dey B, Spitzer TR, Sykes M. Early host CD8 T-cell recovery and sensitized anti-donor interleukin-2-producing and cytotoxic T-cell responses associated with marrow graft rejection following nonmyeloablative allogeneic bone marrow transplantation. Exp Hematol. 2003 Jul; 31(7):609-21.
    View in: PubMed
  67. Spitzer TR, McAfee SL, Dey BR, Colby C, Hope J, Grossberg H, Preffer F, Shaffer J, Alexander SI, Sachs DH, Sykes M. Nonmyeloablative haploidentical stem-cell transplantation using anti-CD2 monoclonal antibody (MEDI-507)-based conditioning for refractory hematologic malignancies. Transplantation. 2003 May 27; 75(10):1748-51.
    View in: PubMed
  68. Christmas P, Carlesso N, Shang H, Cheng SM, Weber BM, Preffer FI, Scadden DT, Soberman RJ. Myeloid expression of cytochrome P450 4F3 is determined by a lineage-specific alternative promoter. J Biol Chem. 2003 Jul 4; 278(27):25133-42.
    View in: PubMed
  69. Manfro GG, Alexandre Netto C, Pollack M, Mezzomo KM, Preffer F, Kradin R. Stress regulates the lymphocyte homing receptor CD62L (L-selectin). Arq Neuropsiquiatr. 2003 Mar; 61(1):20-4.
    View in: PubMed
  70. Treon SP, Kelliher A, Keele B, Frankel S, Emmanouilides C, Kimby E, Schlossman R, Mitsiades N, Mitsiades C, Preffer F, Anderson KC. Expression of serotherapy target antigens in Waldenstrom's macroglobulinemia: therapeutic applications and considerations. Semin Oncol. 2003 Apr; 30(2):248-52.
    View in: PubMed
  71. Mizoguchi A, Mizoguchi E, de Jong YP, Takedatsu H, Preffer FI, Terhorst C, Bhan AK. Role of the CD5 molecule on TCR gammadelta T cell-mediated immune functions: development of germinal centers and chronic intestinal inflammation. Int Immunol. 2003 Jan; 15(1):97-108.
    View in: PubMed
  72. Toh HC, Spitzer TR, Preffer F, Alexander SI, McAfee S, Dombkowski D, Clark JS, Colby C, Saidman S, Sackstein R, Sykes M. Fluctuating lymphocyte chimerism, tolerance and anti-tumor response in a patient with refractory lymphoma receiving nonmyeloablative conditioning and a haploidentical related allogeneic bone marrow transplant. Cytokines Cell Mol Ther. 2002 Dec; 7(2):43-7.
    View in: PubMed
  73. Duan Z, Lamendola DE, Yusuf RZ, Penson RT, Preffer FI, Seiden MV. Overexpression of human phosphoglycerate kinase 1 (PGK1) induces a multidrug resistance phenotype. Anticancer Res. 2002 Jul-Aug; 22(4):1933-41.
    View in: PubMed
  74. Preffer FI, Dombkowski D, Sykes M, Scadden D, Yang YG. Lineage-negative side-population (SP) cells with restricted hematopoietic capacity circulate in normal human adult blood: immunophenotypic and functional characterization. Stem Cells. 2002; 20(5):417-27.
    View in: PubMed
  75. Spitzer TR, McAfee S, Sackstein R, Colby C, Dey B, Saidman S, Preffer F, Alexander S, Sachs DH, Sykes M. Mixed lymphohematopoietic chimerism and delayed donor leukocyte infusions following non-myeloablative conditioning and HLA-matched and mismatched donor bone marrow transplantation. Dicke KA & Keating A, editors. Proceedings: 10th Symposium Auto. Blood and Marrow Transplantation. 2002; 321-332.
  76. Treon SP, Pilarski LM, Belch AR, Kelliher A, Preffer FI, Shima Y, Mitsiades CS, Mitsiades NS, Szczepek AJ, Ellman L, Harmon D, Grossbard ML, Anderson KC. CD20-directed serotherapy in patients with multiple myeloma: biologic considerations and therapeutic applications. J Immunother. 2002 Jan-Feb; 25(1):72-81.
    View in: PubMed
  77. Dong HY, Harris NL, Preffer FI, Pitman MB. Fine-needle aspiration biopsy in the diagnosis and classification of primary and recurrent lymphoma: a retrospective analysis of the utility of cytomorphology and flow cytometry. Mod Pathol. 2001 May; 14(5):472-81.
    View in: PubMed
  78. Kelliher A, Keele B, McBreen M, Preffer FI. Multiparameter Flow Cytometry in the Clinical Laboratory: Present Capacities and Future Projections [CD-ROM]. ADVANCE for Medical Laboratory Professionals. 2001; 13:8-12.
  79. Kratz A, Alexander SI, McAfee SL, Grossberg H, Sackstein R, Colby C, Hope J, Preffer FI, Saidman SL, Weymouth D, Domkowski D, Sachs DH, Spitzer TR, Sykes M. Early predominance of host or donor T–cells correlates with graft failure and GCHD, respectively, in recipients of extensively HLA-mismatched bone marrow transplants following non-myeloablative conditioning. ASH 42nd annual meeting; San Francisco CA. 2000.
  80. Eppich HM, Foxall R, Gaynor K, Dombkowski D, Miura N, Cheng T, Silva-Arrieta S, Evans RH, Mangano JA, Preffer FI, Scadden DT. Pulsed electric fields for selection of hematopoietic cells and depletion of tumor cell contaminants. Nat Biotechnol. 2000 Aug; 18(8):882-7.
    View in: PubMed
  81. Kawai T, Wee SL, Bazin H, Latinne D, Phelan J, Boskovic S, Ko DS, Hong HZ, Mauiyyedi S, Nadazdin O, Abrahamian G, Preffer F, Colvin RB, Sachs DH, Cosimi AB. Association of natural killer cell depletion with induction of mixed chimerism and allograft tolerance in non-human primates. Transplantation. 2000 Jul 27; 70(2):368-74.
    View in: PubMed
  82. Olson D., Kelliher A., Dombkowski D., Preffer F. Clinical monitoring of transplant immunomodulation: Immunosuppression and T-cell clearance with the anti-CD3 monoclonal antibody OKT. The Purdue University Cytometry CD-ROM Volume 5. 2000.
  83. Mizoguchi E, Mizoguchi A, Preffer FI, Bhan AK. Regulatory role of mature B cells in a murine model of inflammatory bowel disease. Int Immunol. 2000 May; 12(5):597-605.
    View in: PubMed
  84. Linette GP, Shankara S, Longerich S, Yang S, Doll R, Nicolette C, Preffer FI, Roberts BL, Haluska FG. In vitro priming with adenovirus/gp100 antigen-transduced dendritic cells reveals the epitope specificity of HLA-A*0201-restricted CD8+ T cells in patients with melanoma. J Immunol. 2000 Mar 15; 164(6):3402-12.
    View in: PubMed
  85. Kradin RL, Sakamoto H, Preffer FI, Dombkowski D, Springer KM, Leary CP. Accumulation of macrophages with dendritic cell characteristics in the pulmonary response to Listeria. Am J Respir Crit Care Med. 2000 Feb; 161(2 Pt 1):535-42.
    View in: PubMed
  86. Penson RT, Kronish K, Duan Z, Feller AJ, Stark P, Cook SE, Duska LR, Fuller AF, Goodman AK, Nikrui N, MacNeill KM, Matulonis UA, Preffer FI, Seiden MV. Cytokines IL-1beta, IL-2, IL-6, IL-8, MCP-1, GM-CSF and TNFalpha in patients with epithelial ovarian cancer and their relationship to treatment with paclitaxel. Int J Gynecol Cancer. 2000 Jan; 10(1):33-41.
    View in: PubMed
  87. Treon SP, Shima Y, Grossbard ML, Preffer FI, Belch AR, Pilarski LM, Anderson KC. Treatment of multiple myeloma by antibody mediated immunotherapy and induction of myeloma selective antigens. Ann Oncol. 2000; 11 Suppl 1:107-11.
    View in: PubMed
  88. Spitzer TR, McAfee S, Sackstein R, Colby C, Toh HC, Multani P, Saidman S, Weyouth DW, Preffer F, Poliquin C, Foley A, Cox B, Andrews D, Sachs DH, Sykes M. Intentional induction of mixed chimerism and achievement of antitumor responses after nonmyeloablative conditioning therapy and HLA-matched donor bone marrow transplantation for refractory hematologic malignancies. Biol Blood Marrow Transplant. 2000; 6(3A):309-20.
    View in: PubMed
  89. Tager AM, Luster AD, Leary CP, Sakamoto H, Zhao LH, Preffer F, Kradin RL. Accessory cells with immunophenotypic and functional features of monocyte-derived dendritic cells are recruited to the lung during pulmonary inflammation. J Leukoc Biol. 1999 Dec; 66(6):901-8.
    View in: PubMed
  90. Masiakos PT, MacLaughlin DT, Maheswaran S, Teixeira J, Fuller AF, Shah PC, Kehas DJ, Kenneally MK, Dombkowski DM, Ha TU, Preffer FI, Donahoe PK. Human ovarian cancer, cell lines, and primary ascites cells express the human Mullerian inhibiting substance (MIS) type II receptor, bind, and are responsive to MIS. Clin Cancer Res. 1999 Nov; 5(11):3488-99.
    View in: PubMed
  91. Treon SP, Shima Y, Preffer FI, Doss DS, Ellman L, Schlossman RL, Grossbard ML, Belch AR, Pilarski LM, Anderson KC. Treatment of plasma cell dyscrasias by antibody-mediated immunotherapy. Semin Oncol. 1999 Oct; 26(5 Suppl 14):97-106.
    View in: PubMed
  92. Dey B, Yang YG, Preffer F, Shimizu A, Swenson K, Dombkowski D, Sykes M. The fate of donor T-cell receptor transgenic T cells with known host antigen specificity in a graft-versus-host disease model. Transplantation. 1999 Jul 15; 68(1):141-9.
    View in: PubMed
  93. Catlin EA, Roberts JD, Erana R, Preffer FI, Ferry JA, Kelliher AS, Atkins L, Weinstein HJ. Transplacental transmission of natural-killer-cell lymphoma. N Engl J Med. 1999 Jul 8; 341(2):85-91.
    View in: PubMed
  94. Lee MM, Seah CC, Masiakos PT, Sottas CM, Preffer FI, Donahoe PK, Maclaughlin DT, Hardy MP. Müllerian-inhibiting substance type II receptor expression and function in purified rat Leydig cells. Endocrinology. 1999 Jun; 140(6):2819-27.
    View in: PubMed
  95. Sykes M, Preffer F, McAfee S, Saidman SL, Weymouth D, Andrews DM, Colby C, Sackstein R, Sachs DH, Spitzer TR. Mixed lymphohaemopoietic chimerism and graft-versus-lymphoma effects after non-myeloablative therapy and HLA-mismatched bone-marrow transplantation. Lancet. 1999 May 22; 353(9166):1755-9.
    View in: PubMed
  96. Vallhonrat H, Williams WW, Cosimi AB, Tolkoff-Rubin N, Ginns LC, Wain JC, Preffer F, Olszak I, Wee S, Delmonico FL, Pascual M. In vivo generation of C4d, Bb, iC3b, and SC5b-9 after OKT3 administration in kidney and lung transplant recipients. Transplantation. 1999 Jan 27; 67(2):253-8.
    View in: PubMed
  97. Shen H, Cheng T, Preffer FI, Dombkowski D, Tomasson MH, Golan DE, Yang O, Hofmann W, Sodroski JG, Luster AD, Scadden DT. Intrinsic human immunodeficiency virus type 1 resistance of hematopoietic stem cells despite coreceptor expression. J Virol. 1999 Jan; 73(1):728-37.
    View in: PubMed
  98. Nguyen PL, Olszak I, Harris NL, Preffer FI. Myeloperoxidase detection by three-color flow cytometry and by enzyme cytochemistry in the classification of acute leukemia. Am J Clin Pathol. 1998 Aug; 110(2):163-9.
    View in: PubMed
  99. Mourad GJ, Preffer FI, Wee SL, Powelson JA, Kawai T, Delmonico FL, Knowles RW, Cosimi AB, Colvin RB. Humanized IgG1 and IgG4 anti-CD4 monoclonal antibodies: effects on lymphocytes in the blood, lymph nodes, and renal allografts in cynomolgus monkeys. Transplantation. 1998 Mar 15; 65(5):632-41.
    View in: PubMed
  100. Mizoguchi A, Mizoguchi E, Smith RN, Preffer FI, Bhan AK. Suppressive role of B cells in chronic colitis of T cell receptor alpha mutant mice. J Exp Med. 1997 Nov 17; 186(10):1749-56.
    View in: PubMed
  101. Sonderby L, Magerstadt R, Blatman RN, Preffer FI and Langhoff E. Selective expression of human fascin (p55) by dendritic leukocytes. Dendritic Cells in Fundamental and Clinical Immunology, edited by Ricciardi-Castagnoli. 1997; Volume3:41-46.
  102. Cheek RF, Olszak I, Madoff S, Preffer FI. In vitro detection of Mycoplasma fermentans binding to B-lymphocytes in fresh peripheral blood using flow cytometry. Cytometry. 1997 May 1; 28(1):90-5.
    View in: PubMed
  103. Meehan SM, McCluskey RT, Pascual M, Preffer FI, Anderson P, Schlossman SF, Colvin RB. Cytotoxicity and apoptosis in human renal allografts: identification, distribution, and quantitation of cells with a cytotoxic granule protein GMP-17 (TIA-1) and cells with fragmented nuclear DNA. Lab Invest. 1997 May; 76(5):639-49.
    View in: PubMed
  104. Sonderbye L, Magerstadt R, Blatman RN, Preffer FI, Langhoff E. Selective expression of human fascin (p55) by dendritic leukocytes. Adv Exp Med Biol. 1997; 417:41-6.
    View in: PubMed
  105. Wang QF, Tilly KI, Tilly JL, Preffer F, Schneyer AL, Crowley WF, Sluss PM. Activin inhibits basal and androgen-stimulated proliferation and induces apoptosis in the human prostatic cancer cell line, LNCaP. Endocrinology. 1996 Dec; 137(12):5476-83.
    View in: PubMed
  106. Chae YS, Flotte T, Hsu DW, Preffer F, Hedley-Whyte ET. Flow cytometric DNA ploidy and cells phase fractions in recurrent human pituitary adenomas. A correlative study of flow cytometric analysis and the expression of proliferating cell nuclear antigen. Gen Diagn Pathol. 1996 Oct; 142(2):89-95.
    View in: PubMed
  107. Ruka W, Taghian A, Gioioso D, Fletcher JA, Preffer F, Suit HD. Comparison between the in vitro intrinsic radiation sensitivity of human soft tissue sarcoma and breast cancer cell lines. J Surg Oncol. 1996 Apr; 61(4):290-4.
    View in: PubMed
  108. Gorski NP, Nouraldin H, Dube DM, Preffer FI, Dombkowski DM, Villa EM, Lewandrowski KB, Weiss RD, Hufford C, Laposata M. Reduced fatty acid ethyl ester synthase activity in the white blood cells of alcoholics. Alcohol Clin Exp Res. 1996 Apr; 20(2):268-74.
    View in: PubMed
  109. Powell SN, DeFrank JS, Connell P, Eogan M, Preffer F, Dombkowski D, Tang W, Friend S. Differential sensitivity of p53(-) and p53(+) cells to caffeine-induced radiosensitization and override of G2 delay. Cancer Res. 1995 Apr 15; 55(8):1643-8.
    View in: PubMed
  110. Perez LA, Dombkowski D, Efird J, Preffer F, Suit HD. Cell proliferation kinetics in human tumor xenografts measured with iododeoxyuridine labeling and flow cytometry: a study of heterogeneity and a comparison between different methods of calculation and other proliferation measurements. Cancer Res. 1995 Jan 15; 55(2):392-8.
    View in: PubMed
  111. Pardo FS, Su M, Borek C, Preffer F, Dombkowski D, Gerweck L, Schmidt EV. Transfection of rat embryo cells with mutant p53 increases the intrinsic radiation resistance. Radiat Res. 1994 Nov; 140(2):180-5.
    View in: PubMed
  112. Marathias K, Pinto C, Rodberg G, Preffer F, Wong J, Kradin R. The T cell antigen receptor CD3:CD4 molecular complex is diminished on the surface of pulmonary lymphocytes. Am J Pathol. 1994 Nov; 145(5):1219-27.
    View in: PubMed
  113. Quintanilla-Martinez L, Preffer F, Rubin D, Ferry JA, Harris NL. CD20+ T-cell lymphoma. Neoplastic transformation of a normal T-cell subset. Am J Clin Pathol. 1994 Oct; 102(4):483-9.
    View in: PubMed
  114. Centeno BA, Zietman AL, Shipley WU, Sobczak ML, Shipley JW, Preffer FI, Boyle BJ, Colvin RB. Flow cytometric analysis of DNA ploidy, percent S-phase fraction, and total proliferative fraction as prognostic indicators of local control and survival following radiation therapy for prostate carcinoma. Int J Radiat Oncol Biol Phys. 1994 Sep 30; 30(2):309-15.
    View in: PubMed
  115. Powelson JA, Knowles RW, Delmonico FL, Kawai T, Mourad G, Preffer FK, Colvin RB, Cosimi AB. CDR-grafted OKT4A monoclonal antibody in cynomolgus renal allograft recipients. Transplantation. 1994 Mar 27; 57(6):788-93.
    View in: PubMed
  116. Oyama T, Vickery AL, Preffer FI, Colvin RB. A comparative study of flow cytometry and histopathologic findings in thyroid follicular carcinomas and adenomas. Hum Pathol. 1994 Mar; 25(3):271-5.
    View in: PubMed
  117. Centeno BA, Louis DN, Kupsky WJ, Preffer FI, Sobel RA. The AgNOR technique, PCNA immunohistochemistry, and DNA ploidy in the evaluation of choroid plexus biopsy specimens. Am J Clin Pathol. 1993 Dec; 100(6):690-6.
    View in: PubMed
  118. Haug CE, Colvin RB, Delmonico FL, Auchincloss H, Tolkoff-Rubin N, Preffer FI, Rothlein R, Norris S, Scharschmidt L, Cosimi AB. A phase I trial of immunosuppression with anti-ICAM-1 (CD54) mAb in renal allograft recipients. Transplantation. 1993 Apr; 55(4):766-72; discussion 772-3.
    View in: PubMed
  119. Delmonico FL, Knowles RW, Colvin RB, Cavender DE, Kawai T, Bedle M, Stroka D, Preffer FI, Haug C, Cosimi AB. Immunosuppression of cynomolgus renal allograft recipients with humanized OKT4A monoclonal antibodies. Transplant Proc. 1993 Feb; 25(1 Pt 1):784-5.
    View in: PubMed
  120. Preffer FI. Flow Cytometry. Colvin RB, Bhan AK, McCluskey RT, editors. Diagnostic Immunopathology. 1993; 725-749.
  121. Pastel-Levy C, Bell DA, Rosenberg AE, Preffer F, Colvin RB, Flotte TJ. DNA flow cytometry of epithelioid sarcoma. Cancer. 1992 Dec 15; 70(12):2823-6.
    View in: PubMed
  122. Eichhorn JH, Bell DA, Young RH, Swymer CM, Flotte TJ, Preffer RI, Scully RE. DNA content and proliferative activity in ovarian small cell carcinomas of the hypercalcemic type. Implications for diagnosis, prognosis, and histogenesis. Am J Clin Pathol. 1992 Dec; 98(6):579-86.
    View in: PubMed
  123. MacLaughlin DT, Levin RK, Catlin EA, Taylor LA, Preffer FI, Donahoe PK. Identification of müllerian inhibiting substance specific binding in human cell lines. Horm Metab Res. 1992 Dec; 24(12):570-5.
    View in: PubMed
  124. Kurban RS, Preffer FI, Sober AJ, Mihm MC, Barnhill RL. Occurrence of melanoma in "dysplastic" nevus spilus: report of case and analysis by flow cytometry. J Cutan Pathol. 1992 Oct; 19(5):423-8.
    View in: PubMed
  125. Jacoby AF, Young RH, Colvin RB, Flotte TJ, Preffer F, Scully RE, Swymer CM, Bell DA. DNA content in juvenile granulosa cell tumors of the ovary: a study of early- and advanced-stage disease. Gynecol Oncol. 1992 Jul; 46(1):97-103.
    View in: PubMed
  126. Hug EB, Donnelly SM, Shipley WU, Heney NM, Kaufman DS, Preffer FI, Schwartz SM, Colvin RB, Althausen AF. Deoxyribonucleic acid flow cytometry in invasive bladder carcinoma: a possible predictor for successful bladder preservation following transurethral surgery and chemotherapy-radiotherapy. J Urol. 1992 Jul; 148(1):47-51.
    View in: PubMed
  127. Wee SL, Stroka DM, Preffer FI, Jolliffe LK, Colvin RB, Cosimi AB. The effects of OKT4A monoclonal antibody on cellular immunity of nonhuman primate renal allograft recipients. Transplantation. 1992 Mar; 53(3):501-7.
    View in: PubMed
  128. Flotte TJ, Pastel-Levy C, Graeme-Cook F, Preffer F, Bell DA. DNA flow cytometry of primary tumors and their skin metastases. Correlation of DNA histograms. Am J Dermatopathol. 1992 Feb; 14(1):19-23.
    View in: PubMed
  129. Eichhorn JH, Bell DA, Young RH, Swymer C, Flotte TJ, Colvin RB, Preffer FI, Scully RE. DNA content and proliferative activity in ovarian small cell carcinomas of the hypercalcemic type: Implications for diagnosis, prognosis and histogenesis. Am. J. Clin. Pathol. 1992; 98:579-86.
  130. Marathias KP, Preffer FI, Pinto C, Kradin RL. Most human pulmonary infiltrating lymphocytes display the surface immune phenotype and functional responses of sensitized T cells. Am J Respir Cell Mol Biol. 1991 Nov; 5(5):470-6.
    View in: PubMed
  131. Colvin RB, Preffer FI. Laboratory monitoring of therapy with OKT3 and other murine monoclonal antibodies. Clin Lab Med. 1991 Sep; 11(3):693-714.
    View in: PubMed
  132. Pastel-Levy C, Flotte TJ, Preffer F, Ware A, Graeme-Cook F, Bell DA, Colvin RB. Application of DNA flow cytometry from paraffin-embedded tissue to the diagnosis of mycosis fungoides. J Cutan Pathol. 1991 Aug; 18(4):279-83.
    View in: PubMed
  133. Cosimi AB, Delmonico FL, Wright JK, Wee SL, Preffer FI, Bedle M, Colvin RB. OKT4A monoclonal antibody immunosuppression of cynomolgus renal allograft recipients. Transplant Proc. 1991 Feb; 23(1 Pt 1):501-3.
    View in: PubMed
  134. Wee SL, Cosimi AB, Preffer FI, Rothlein R, Faanes R, Conti D, Colvin RB. Functional consequences of anti-ICAM-1 (CD54) in cynomolgus monkeys with renal allografts. Transplant Proc. 1991 Feb; 23(1 Pt 1):279-80.
    View in: PubMed
  135. Graeme-Cook F, Bell DA, Flotte TJ, Preffer F, Pastel-Levy C, Nardi G, Compton C. Aneuploidy in pancreatic insulinomas does not predict malignancy. Cancer. 1990 Dec 1; 66(11):2365-8.
    View in: PubMed
  136. Cosimi AB, Delmonico FL, Wright JK, Wee SL, Preffer FI, Jolliffe LK, Colvin RB. Prolonged survival of nonhuman primate renal allograft recipients treated only with anti-CD4 monoclonal antibody. Surgery. 1990 Aug; 108(2):406-13; discussion 413-4.
    View in: PubMed
  137. Cosimi AB, Conti D, Delmonico FL, Preffer FI, Wee SL, Rothlein R, Faanes R, Colvin RB. In vivo effects of monoclonal antibody to ICAM-1 (CD54) in nonhuman primates with renal allografts. J Immunol. 1990 Jun 15; 144(12):4604-12.
    View in: PubMed
  138. Wee SL, Colvin RB, Phelan JM, Preffer FI, Reichert TA, Berd D, Cosimi AB. Fc-receptor for mouse IgG1 (Fc gamma RII) and antibody-mediated cell clearance in patients treated with Leu2a antibody. Transplantation. 1989 Dec; 48(6):1012-7.
    View in: PubMed
  139. Colvin RB, Preffer FI, Fuller TC, Brown MC, Ip SH, Kung PC, Cosimi AB. A critical analysis of serum and urine interleukin-2 receptor assays in renal allograft recipients. Transplantation. 1989 Nov; 48(5):800-5.
    View in: PubMed
  140. Ramsay J, Zietman A, Preffer F, Suit HD. The growth and cell kinetics of a secondary tumor after radiation or surgical treatment of the primary tumor. Int J Radiat Oncol Biol Phys. 1989 Oct; 17(4):809-13.
    View in: PubMed
  141. Kradin R, Kurnick J, Gifford J, Pinto C, Preffer F, Lazarus D. Adoptive immunotherapy with interleukin-2 (IL-2) results in diminished IL-2 production by stimulated peripheral blood lymphocytes. J Clin Immunol. 1989 Sep; 9(5):378-85.
    View in: PubMed
  142. Preffer FI, Kim CW, Fischer KH, Sabga EM, Kradin RL, Colvin RB. Identification of pre-T cells in human peripheral blood. Extrathymic differentiation of CD7+CD3- cells into CD3+ gamma/delta+ or alpha/beta+ T cells. J Exp Med. 1989 Jul 1; 170(1):177-90.
    View in: PubMed
  143. Kradin RL, Kurnick JT, Lazarus DS, Preffer FI, Dubinett SM, Pinto CE, Gifford J, Davidson E, Grove B, Callahan RJ, et al. Tumour-infiltrating lymphocytes and interleukin-2 in treatment of advanced cancer. Lancet. 1989 Mar 18; 1(8638):577-80.
    View in: PubMed
  144. Kradin RL, Kurnick JT, Preffer FI, Dubinett SM, Dickersin GR, Pinto C. Adoptive immunotherapy with IL-2 results in the loss of delayed-type hypersensitivity responses and the development of immediate hypersensitivity to recall antigens. Clin Immunol Immunopathol. 1989 Feb; 50(2):184-95.
    View in: PubMed
  145. Colvin RB, Preffer FI, Fuller T, Brown M, Ip S, Kung P, Cosimi AB. A critical analysis of serum and urine interleukin 2 receptor assays in renal allograft recipients. Transplant Proc. 1989 Feb; 21(1 Pt 2):1863.
    View in: PubMed
  146. Wee SL, Phelan JM, Preffer FI, Colvin RB, Cosimi AB. Anti-Leu2a (anti-CD8) monoclonal antibody therapy: antibody-mediated cell clearance in vivo requires Fc-FcRII interaction. Transplant Proc. 1989 Feb; 21(1 Pt 1):117-8.
    View in: PubMed
  147. Ramsay J, Suit HD, Preffer FI, Sedlacek R. Changes in bromodeoxyuridine labeling index during radiation treatment of an experimental tumor. Radiat Res. 1988 Dec; 116(3):453-61.
    View in: PubMed
  148. Kradin R, Dubinett S, Mullin J, Boyle L, Strauss HW, Bourgoin PM, Preffer FI, Kurnick J. Treatment of patients with advanced cancer using tumor-infiltrating lymphocytes and interleukin 2. Transplant Proc. 1988 Apr; 20(2):336-8.
    View in: PubMed
  149. Preffer FI. Flow cytometry. Colvin RB, Bhan AK, McCluskey RT, editors. Diagnostic Immunopathology. 1988; 453-473.
  150. Colvin RB, Preffer FI. New technologies in cell analysis by flow cytometry. Arch Pathol Lab Med. 1987 Jul; 111(7):628-32.
    View in: PubMed
  151. Stegagno M, Boyle LA, Preffer FI, Leary CP, Colvin RB, Cosimi AB, Kurnick JT. Functional analysis of T cell subsets and clones in human renal allograft rejection. Transplant Proc. 1987 Feb; 19(1 Pt 1):394-7.
    View in: PubMed
  152. Kradin RL, Boyle LA, Preffer FI, Callahan RJ, Barlai-Kovach M, Strauss HW, Dubinett S, Kurnick JT. Tumor-derived interleukin-2-dependent lymphocytes in adoptive immunotherapy of lung cancer. Cancer Immunol Immunother. 1987; 24(1):76-85.
    View in: PubMed
  153. Udall JN, Moscicki RA, Preffer FI, Ariniello PD, Carter EA, Bhan AK, Bloch KJ. Flow cytometry: a new approach to the isolation and characterization of Kupffer cells. Adv Exp Med Biol. 1987; 216A:821-7.
    View in: PubMed
  154. Preffer FI, Colvin RB. Analysis and sorting by flow cytometry: Application to the study of human disease. Pretlow TG, Pretlow TP, editors. Cell Separation: Methods and Selected Application. 1987; 311-347.
  155. Preffer FI, Colvin RB, Leary CP, Boyle LA, Tuazon TV, Lazarovits AI, Cosimi AB, Kurnick JT. Two-color flow cytometry and functional analysis of lymphocytes cultured from human renal allografts: identification of a Leu-2+3+ subpopulation. J Immunol. 1986 Nov 1; 137(9):2823-30.
    View in: PubMed
  156. Kradin RL, McCarthy KM, Preffer FI, Schneeberger EE. Flow-cytometric and ultrastructural analysis of alveolar macrophage maturation. J Leukoc Biol. 1986 Oct; 40(4):407-17.
    View in: PubMed
  157. Kabawat SE, Preffer FI, Bhan AK. Monoclonal antibodies in diagnostic pathology. Ferrone S, Dierich MP, editors. Handbook of Monoclonal Antibodies: applications in biology and medicine. 1985; 293-328.
  158. Preffer F.I. Immune Evaluation of patients with selected malignant disease: Laboratory and clinical studies of subcellular factors. 1981.
  159. Marbella PC, Takita H, Lane WW, Preffer FI. Squamous cell carcinoma of the lung. Clinicopathologic study. Chest. 1977 Apr; 71(4):497-501.
    View in: PubMed
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact Human Resources at faculty_serviceshms.harvard.edu.
Preffer's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts
_
Co-Authors
_
Similar People
_
Same Department
Physical Neighbors
_